Aeluma remains in a high-risk, pre-commercial semiconductor development phase characterized by extreme revenue volatility and a reliance on dilutive equity financing to fund ongoing R&D. While the company has bolstered its cash position to $37.8 million as of ...
Price trend, volume and key moving averages
Trailing total returns as of 10/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Sep 16, 2026 | -$0.15-100.0% vs -$0.07 | $582,000+1.2% vs $575,000 |
Q2 2026 May 13, 2026 | -$0.04-14.3% vs -$0.04 | $1M-10.1% vs $1M |
Q1 2026 Feb 11, 2026 | -$0.04+20.0% vs -$0.05 | $1M-8.8% vs $1M |
Q4 2025 Nov 12, 2025 | -$0.03-20.0% vs -$0.03 | $1M+9.9% vs $1M |
Aeluma, Inc. (NASDAQ: ALMU - Get Free Report) CEO Jonathan Klamkin sold 100,000 shares of the business's stock in a transaction that occurred on Monday, September 21st. The shares were sold at an average price of $13.35, for a total value of $1,335,000.00. Following the completion of the sale, the chief executive officer directly owned 1,226,995
Aeluma's Q4 revenue plunged 56% to $582,000 as management shifted resources from government R&D toward commercial AI datacom opportunities. Multimillion-dollar AI datacom NRE negotiations could provide the first meaningful evidence that customer evaluations are converting into commercial programs. Aeluma ended FY2026 with $56 million cash and nearly zero debt, providing runway for its commercialization push.
However, Aeluma is not a run-of-the-mill startup, and a catalyst is in play that investors can capitalize on. The company is in the midst of a major transition, from research, development, and niche production to scalable manufacturing of advanced photonic equipment.
Aeluma, Inc. (ALMU) Q4 2026 Earnings Call Transcript
Benchmark ALMU against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Aeluma, Inc. (ALMU)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $7.17 | $101.6M | -31.17 | 407.62% | -64.78% | -29.96% | — | |
| $752.54 | $58.55B | 2033.89 | 21.03% | -230.1% | -300.07% | — | |
| $63.12 | $2.77B | -35.46 | 37.15% | -13.48% | -9.34% | — | |
| $5.33 | $703.63M | -7.84 | 2494.6% | -4420.65% | -19.59% | — | |
| $87.45 | $4.09B | 17.21 | 0.45% | 32.24% | 11.35% | — | |
| $68.07 | $5.46B | -106.36 | 82.75% | -9.57% | -5.61% | — |
Aeluma, Inc. (ALMU) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Aeluma, Inc. (ALMU) SEC filings — annual & quarterly reports (10-K, 10-Q)
Sep 16, 2026·SEC
May 19, 2026·SEC
May 13, 2026·SEC
Get notified when ALMU posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Aeluma, Inc. (ALMU) stock FAQ — growth, dividends, profitability & financials explained
Aeluma, Inc. (ALMU) reported $4.5M in revenue for fiscal year 2025.
Aeluma, Inc. (ALMU) grew revenue by 407.6% over the past year. This is strong growth.
Aeluma, Inc. (ALMU) reported a net loss of $9.2M for fiscal year 2025.
Aeluma, Inc. (ALMU) has a return on equity (ROE) of -30.0%. Negative ROE indicates the company is unprofitable.
Aeluma, Inc. (ALMU) had negative free cash flow of $4.2M in fiscal year 2025, likely due to heavy capital investments.
